On June 6, Gelunhui reported that Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that as of June 6, 2024, the company had cumulatively repurchased 7,201,536 shares of the company's stock through a special repurchase securities account in a centralized bidding manner, accounting for 3.10% of the total share capital of the company; the highest transaction price for the repurchased shares was 20.98 yuan/share, the lowest transaction price was 18.17 yuan/share, and the total transaction amount was 142 million yuan (excluding transaction fees).
明德生物(002932.SZ)：已累计回购3.10%股份
Wuhan Easy Diagnosis Biomedicine (002932.SZ): has cumulatively repurchased 3.10% of shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.